Filter
964
Text search:
drug-resistance
infections
Featured
Recommendations
102
New Publications
287
Language
Document type
No document type
634
Studies & Reports
129
Guidelines
123
Manuals
26
Strategic & Response Plan
23
Fact sheets
10
Training Material
9
Situation Updates
6
Infographics
4
Countries / Regions
India
54
Ethiopia
28
South Africa
28
Tanzania
27
Western and Central Europe
26
Nepal
25
Kenya
24
Eastern Europe
19
Zambia
18
Malawi
18
Africa
18
Uganda
15
Namibia
15
Asia
15
Nigeria
14
Ghana
14
Cambodia
13
Sierra Leone
11
Liberia
11
Rwanda
10
Lesotho
10
Latin America and the Carribbean
10
Russia
10
Zimbabwe
9
Bangladesh
9
Myanmar / Burma
9
South–East Asia Region
8
Ukraine
7
Global
7
Philippines
6
Botswana
6
Senegal
5
Cameroon
5
Pakistan
5
Eswatini/ Swaziland
5
Mozambique
4
East and Southern Africa
4
Albania
4
Burkina Faso
3
Indonesia
3
West and Central Africa
3
Middle East and North Africa
3
Venezuela
3
Vietnam
3
Guinea
2
Haiti
2
Afghanistan
2
Thailand
2
China
2
Sri Lanka
2
Western Pacific Region
2
Laos
2
Georgia
2
Gabon
2
Congo, Democratic Republic of
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
South Sudan
1
Iraq
1
Jordan
1
Lebanon
1
Egypt
1
Gambia
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Brazil
1
Serbia
1
Eastern Europe and Central Asia
1
Paraguay
1
Bhutan
1
Armenia
1
Timor Leste/ East Timor
1
Tajikistan
1
Estonia
1
Iran
1
Turkmenistan
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
359
Clinical Guidelines
109
Public Health
30
Women & Child Health
21
Pharmacy & Technologies
17
Capacity Building
8
Key Resources
7
Toolboxes
TB
191
HIV
188
AMR
143
NTDs
23
Pharmacy
17
Planetary Health
12
Polio
9
Ebola
8
Global Health Education
8
Rapid Response
7
Refugee
7
Caregiver
7
COVID-19
6
Natural Hazards
3
Mental Health
3
Health Financing Toolbox
3
NCDs
3
Cholera
2
Conflict
2
Disability
1
Zika
1
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected
...
Human African Trypanosomiasis (HAT, sleeping sickness) and Animal African Trypanosomiasis (AAT) are neglected tropical diseases generally caused by the same etiological agent, Trypanosoma brucei. Despite important advances in the reduction or disappearance of HAT cases, AAT represents a risky reserv
...
3rd edition
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati
...
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- and XDR-TB, health workers in
TB clinics (in district hospitals and some accredited health centres) wil
...
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected
...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama
...
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected
...
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on
...
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organ
...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
International Journal of Drug Policy 24 (2013) e91-98
Harm reduction: evidence, impacts and challenges
-10-
